
Auspex Diagnostics focuses on developing and providing advanced cancer diagnostics services to medical professionals and patients, helping to personalize cancer treatment plans and improve patients’ quality of living. By leveraging advanced data analytics technologies, the company aims to provide cancer patients and oncologists with the necessary tools to make the best data-driven treatment decisions and improve the quality of care.

Auspex Diagnostics focuses on developing and providing advanced cancer diagnostics services to medical professionals and patients, helping to personalize cancer treatment plans and improve patients’ quality of living. By leveraging advanced data analytics technologies, the company aims to provide cancer patients and oncologists with the necessary tools to make the best data-driven treatment decisions and improve the quality of care.
Founded: 2009
Headquarters: Warren, New Jersey, United States
Focus: Gene-expression–based cancer diagnostics to personalize treatment and predict recurrence
Recent support: MassChallenge non-equity assistance (Jul 2023); Seed/accelerator activity with TMU BioMed Accelerator (Feb 2024)
Personalized oncology diagnostics; recurrence risk prediction and chemotherapy efficacy prediction
2009
Biotechnology
Non-equity assistance reported
Seed/accelerator activity reported